Overview
Shop our Cls Substrate, C2 (5-FAM/QXL® 520) – 0.5 mg for your research needs. This peptide, known as the second complement component (C2), serves as the physiological substrate for the proenzyme Cls, a crucial element in the body’s defense system. The complement system is essential for protecting against pathogens, but it can also lead to inflammation in certain conditions. As the first complement component, the C1s protease activates the host defense pathway effectively. This specific peptide utilizes the 5FAM/QXL® 520 FRET pair, allowing for precise quantitation of complement enzyme activity, which is vital for your experimental accuracy.
Key Features
- Designed for quantifying complement enzyme activity
- Utilizes 5FAM/QXL® 520 FRET pair
- Supports research in immunology and inflammation
- High purity and reliable performance
- Available in a convenient 0.5 mg size
Specifications
| Product Name | Cls Substrate, C2 (5-FAM/QXL® 520) |
| Size | 0.5 mg |
| Category | Peptides |
| Application | Quantitation of complement enzyme activity |
FAQ
What is the role of C2 in the immune system?
C2 is part of the complement system, which helps the body identify and eliminate pathogens. It is crucial in mediating immune responses and can contribute to inflammation under pathological conditions.
How does the FRET pair work in this substrate?
The 5FAM/QXL® 520 FRET pair allows for sensitive detection of enzyme activity. When the enzyme acts on the substrate, it generates a measurable signal that reflects the level of activity, providing valuable data for your experiments.
Can I find related products for my research?
Yes! We offer a variety of other peptides and substrates, such as the PKG Substrate and Autocamtide-2which complement your research on enzyme activity and detection.
Order the Cls Substrate, C2 (5-FAM/QXL® 520) – 0.5 mg now to enhance your research capabilities. Dive deeper into your studies with this essential tool in immunology.
Related Products
Browse more in Peptides.




Reviews
There are no reviews yet.